MedPath

Chronic Grape Extract in Crosstraining Athletes: A Randomized Crossover Trial

Not Applicable
Not yet recruiting
Conditions
Performance
Registration Number
NCT07106281
Lead Sponsor
Universidad de Granada
Brief Summary

The aim of this study is to investigate the effect of cronic GSE intake in crosstraining may have a favorable impact on biochemical markers, recovery, and performance.

Detailed Description

Supplementation with certain antioxidant nutrients is a feasible strategy to accelerate recovery from fatigue and prevent exercise-induced oxidative damage. Grape seed extract (GSE) contains flavonoids such as proanthocyanidins, which are potent antioxidants with numerous health benefits. Therefore, optimizing the recovery process after training is essential for athletes engaged in strength and power sports who aim to enhance performance.

Thirty trained CrossFit athletes consumed grape seed extract or a placebo for one week. The training session consisted of a 12-minute strength block, a 13-minute metabolic conditioning (MetCon), and a final 15-minute MetCon. The Rating of Perceived Exertion (RPE), Gastrointestinal Distress Score (GDS), blood pressure and the Perceived Recovery Status scale (RPS) were administered at the beginning of the session and at the end of each segment of the CrossFit session. DOMS was assessed using a visual analog scale at 24 and 48 hours after the CrossFit session.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Age: 18-35 years.
  • Body mass index: 18.5-30 kg/m2.
  • Ability to understand the instructions, objectives, and study protocol.
  • Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
  • Resident on the island of Tenerife.
Exclusion Criteria
  • History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
  • Any chronic pathology in which the intake of nutritional supplements, especially use of antioxidant supplements during the 4 weeks prior to the start of the study.
  • Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
  • Use of medications that may affect the study results.
  • Unstable body weight for 3 months prior to the start of the study (> 4 kg loss or gain in weight).
  • Active tobacco abuse or illicit drug use, or history of treatment for alcohol abuse.
  • On a special diet or prescribed for other reasons (e.g., celiac disease).

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Performance60 minutes

Deep squat test at 70% of repetition maximum

Secondary Outcome Measures
NameTimeMethod
Attention60 minutes

Selective attention and inhibitory control measured by the Stroop test

Performance: Weight used in the crosstraining session60 minutes

Weight used in the crosstraining session

Performance: Time performed in the crosstraining session60 minutes

Time performed in the crosstraining session

Subjective fatigue throug the the RPE scale60 minutes

Rate of perceived exertion scale

Gastrointestinal distress60 minutes

Gastrointestinal distress through the Gastrointestinal Distress Score (GDS)

Biochemical parameters48 hours

Biochemical parameters of muscle damage: Glutamate oxaloacetate transaminase (GOT), glutamate pyruvate transaminase (GPT), creatine kinase (CK), urea, lactate dehydrogenase (LDH), myoglobin, glutathione peroxidase (GPx), catalase, superoxide dismutase (SOD), and interleukin 6 (IL-6)

Recovery60 minutes

Perceived Recovery Status Scale (RPS)

Delayed-onset muscle soreness (DOMS)24 hours

Delayed-onset muscle soreness (DOMS) scale (0-10 arbitrary units)

Capillar lactate levels60 minutes

Capillar lactate levels

Heart rate60 minutes

Heart rate

Blood pressure60 minutes

Blood pressure

Trial Locations

Locations (1)

Universidad de la Laguna

🇪🇸

Santa Cruz De Tenerife, Spain

Universidad de la Laguna
🇪🇸Santa Cruz De Tenerife, Spain
Alejandro R. Triviño
Contact
616 53 57 61
nutrievidence@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.